These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32237921)

  • 1. Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer.
    Zhang X; Song H; Canup BSB; Xiao B
    Expert Opin Drug Deliv; 2020 Jun; 17(6):781-790. PubMed ID: 32237921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
    Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
    World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-enabled colorectal cancer therapy.
    Pan Q; Fan X; Xie L; Wu D; Liu R; Gao W; Luo K; He B; Pu Y
    J Control Release; 2023 Oct; 362():548-564. PubMed ID: 37683732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight to drug delivery aspects for colorectal cancer.
    Gulbake A; Jain A; Jain A; Jain A; Jain SK
    World J Gastroenterol; 2016 Jan; 22(2):582-99. PubMed ID: 26811609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
    Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
    J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Armamentarium in Drug Delivery for Colorectal Cancer.
    Ali A; Akhtar J; Ahmad U; Basheer AS; Jaiswal N; Jahan A
    Crit Rev Ther Drug Carrier Syst; 2022; 40(1):1-48. PubMed ID: 36374840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer.
    Li C; Cai G; Song D; Gao R; Teng P; Zhou L; Ji Q; Sui H; Cai J; Li Q; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3627-3639. PubMed ID: 31328737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment.
    Hameedat F; Pizarroso NA; Teixeira N; Pinto S; Sarmento B
    Eur J Pharm Sci; 2022 Sep; 176():106259. PubMed ID: 35842140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.
    Krishnaiah YS; Khan MA
    Pharm Dev Technol; 2012; 17(5):521-40. PubMed ID: 22681390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting into the colon: approaches to target colorectal cancer.
    Patel MM
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1343-50. PubMed ID: 24898947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in antibody derivatives against colorectal cancer; A review.
    Ghani S; Bahrami S; Rafiee B; Eyvazi S; Yarian F; Ahangarzadeh S; Khalili S; Shahzamani K; Jafarisani M; Bandehpour M; Kazemi B
    Life Sci; 2021 Jan; 265():118791. PubMed ID: 33220288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
    Wang K; Shen R; Meng T; Hu F; Yuan H
    Molecules; 2022 May; 27(9):. PubMed ID: 35566331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basics to advances in nanotherapy of colorectal cancer.
    Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
    Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.
    Urbanska AM; Zhang X; Prakash S
    Cell Biochem Biophys; 2015 Jul; 72(3):757-69. PubMed ID: 27352189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and advancing treatments for metastatic colorectal cancer.
    Sanz-Garcia E; Grasselli J; Argiles G; Elez ME; Tabernero J
    Expert Opin Biol Ther; 2016; 16(1):93-110. PubMed ID: 26549053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature.
    Wang C; Zhao M; Liu YR; Luan X; Guan YY; Lu Q; Yu DH; Bai F; Chen HZ; Fang C
    Biomaterials; 2014 Jan; 35(4):1215-26. PubMed ID: 24231414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation.
    Li B; Zu M; Jiang A; Cao Y; Wu J; Shahbazi MA; Shi X; Reis RL; Kundu SC; Xiao B
    Biomaterials; 2024 Jun; 307():122530. PubMed ID: 38493672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome technologies towards colorectal cancer therapeutics.
    Sang R; Stratton B; Engel A; Deng W
    Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.